Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives

Fraser, M; Seetharamu, N; Diamond, M; Lee, CS

Lee, CS (通讯作者),Northwell Hlth Canc Inst, Div Med Oncol & Hematol, Lake Success, NY 11042 USA.;Lee, CS (通讯作者),St Johns Univ, Dept Clin Hlth Profess, Queens, NY 11432 USA.

CANCER MANAGEMENT AND RESEARCH, 2023; 15 (): 1233

Abstract

Aberrant c-MET (Mesenchymal-Epithelial Transition) signaling contributes to cancer cell development, proliferation, and metastases of non-small cell l......

Full Text Link